Study of passage of a structured phospholipid "AceDoPC" through an in vitro reconstituted blood-brain barrier and its cerebral bioavailability in vivo in rats
Identifieur interne : 000422 ( Main/Exploration ); précédent : 000421; suivant : 000423Study of passage of a structured phospholipid "AceDoPC" through an in vitro reconstituted blood-brain barrier and its cerebral bioavailability in vivo in rats
Auteurs : Mayssa Hachem [France]Source :
Descripteurs français
- mix :
English descriptors
- mix :
Abstract
Docosahexaenoic acid (DHA, 22:6n-3) is the main essential omega-3 fatty acid in brain tissues required for normal brain development and function. A decrease in the cerebral concentration of DHA is observed in patients suffering from neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Targeted intake of DHA to the brain could compensate for these deficiencies. Blood DHA is transported across the blood-brain barrier (BBB) more efficiently when esterified at the sn-2 position of lysophosphatidylcholine (lysoPC). We produce in the laboratory a structured phosphatidylcholine to mimic 2-docosahexaenoyl-lysoPC (lysoPC-DHA), named AceDoPC (1-acetyl,2-docosahexaenoyl-glycerophosphocholine), that may be considered as a stabilized form of the physiological lysoPC-DHA and that is neuroprotective in experimental ischemic stroke. The first objective of this work was to compare the passage of either labeled unesterified DHA or DHA esterified in AceDoPC or in phosphatidylcholine (PC-DHA), bound to plasma, through an in vitro model of the BBB. This model is constituted of a co-culture of bovine brain capillary endothelial cells and glial cells from newborn rats. We show a preferential passage through the endothelial monolayer and a preferential uptake by glial cells of AceDoPC compared to unesterified DHA and PC-DHA. We also show that AceDoPC is hydrolyzed, partly, into lysoPC-DHA and that phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are the most labeled lipid classes in endothelial cells and glial cells. AceDoPC is found, partly, as a whole molecule in the cells. The second objective of this work was to confirm whether this preference for AceDoPC was also observed in vivo. We studied, in 20 days old rats, the brain uptake of different forms of DHA previously used (DHA, AceDoPC, PC-DHA). We demonstrate that AceDoPC provided the brain with DHA more efficiently than the other forms of DHA and that this preference for AceDoPC is specific for the brain because it is not observed for other studied organs. AceDoPC is found, partly, intact in the brain. Ex vivo autoradiography of rat brain reveals that DHA provided from AceDoPC is localized in specific brain regions playing key roles in memory and cognitive functions. Finally, by using molecular modelling approaches, we demonstrate that electrostatic and hydrophobic potentials are distributed very similarly at the surfaces of AceDoPC and lysoPC-DHA. In conclusion, our studies demonstrate that AceDoPC is a privileged and specific carrier of DHA to the brain. Considering the essential roles of DHA for the brain, this new approach to target the brain with DHA offers promising perspectives in the development of preventive and therapeutic strategies for neurological diseases.
Url:
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: 000A47
- to stream Hal, to step Curation: 000A47
- to stream Hal, to step Checkpoint: 000164
- to stream Main, to step Merge: 000424
- to stream Main, to step Curation: 000422
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Study of passage of a structured phospholipid "AceDoPC" through an in vitro reconstituted blood-brain barrier and its cerebral bioavailability in vivo in rats</title>
<title xml:lang="fr">Etude du passage d’un phospholipide structuré « AceDoPC » à travers une barrière hémato-encéphalique reconstituée in vitro et de sa biodisponibilité cérébrale in vivo chez le rat</title>
<author><name sortKey="Hachem, Mayssa" sort="Hachem, Mayssa" uniqKey="Hachem M" first="Mayssa" last="Hachem">Mayssa Hachem</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-139835" status="VALID"><orgName>Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition</orgName>
<orgName type="acronym">CarMeN</orgName>
<desc><address><addrLine>Faculté de Médecine Lyon Sud - BP 12 - 165 Chemin du Grand Revoyet - 69921 Oullins cedex INSA, Bât. IMBL, La Doua - 11 Avenue Jean Capelle - 69621 Villeurbanne Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://carmen.univ-lyon1.fr/</ref>
</desc>
<listRelation><relation name="U1060" active="#struct-303623" type="direct"></relation>
<relation active="#struct-300074" type="direct"></relation>
<relation active="#struct-194495" type="direct"></relation>
<relation active="#struct-219748" type="direct"></relation>
<relation name="USC-1235" active="#struct-92114" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="U1060" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300074" type="direct"><org type="institution" xml:id="struct-300074" status="VALID"> <orgName>Hospices Civils de Lyon</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-194495" type="direct"><org type="institution" xml:id="struct-194495" status="VALID"><orgName>Université Claude Bernard Lyon 1</orgName>
<orgName type="acronym">UCBL</orgName>
<desc><address><addrLine>43, boulevard du 11 novembre 1918, 69622 Villeurbanne cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-lyon1.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-219748" type="direct"><org type="institution" xml:id="struct-219748" status="VALID"><orgName>Institut National des Sciences Appliquées Lyon</orgName>
<orgName type="acronym">INSA Lyon</orgName>
<desc><address><addrLine>20 Avenue Albert Einstein, 69621 Villeurbanne cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.insa-lyon.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="USC-1235" active="#struct-92114" type="direct"><org type="institution" xml:id="struct-92114" status="VALID"> <orgName>Institut National de la Recherche Agronomique</orgName>
<orgName type="acronym">INRA</orgName>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.inra.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="university">Université Claude Bernard Lyon 1</orgName>
<orgName type="institution" wicri:auto="newGroup">Université de Lyon</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:tel-01368259</idno>
<idno type="halId">tel-01368259</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-01368259</idno>
<idno type="url">https://tel.archives-ouvertes.fr/tel-01368259</idno>
<date when="2015-05-22">2015-05-22</date>
<idno type="wicri:Area/Hal/Corpus">000A47</idno>
<idno type="wicri:Area/Hal/Curation">000A47</idno>
<idno type="wicri:Area/Hal/Checkpoint">000164</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000164</idno>
<idno type="wicri:Area/Main/Merge">000424</idno>
<idno type="wicri:Area/Main/Curation">000422</idno>
<idno type="wicri:Area/Main/Exploration">000422</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Study of passage of a structured phospholipid "AceDoPC" through an in vitro reconstituted blood-brain barrier and its cerebral bioavailability in vivo in rats</title>
<title xml:lang="fr">Etude du passage d’un phospholipide structuré « AceDoPC » à travers une barrière hémato-encéphalique reconstituée in vitro et de sa biodisponibilité cérébrale in vivo chez le rat</title>
<author><name sortKey="Hachem, Mayssa" sort="Hachem, Mayssa" uniqKey="Hachem M" first="Mayssa" last="Hachem">Mayssa Hachem</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-139835" status="VALID"><orgName>Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition</orgName>
<orgName type="acronym">CarMeN</orgName>
<desc><address><addrLine>Faculté de Médecine Lyon Sud - BP 12 - 165 Chemin du Grand Revoyet - 69921 Oullins cedex INSA, Bât. IMBL, La Doua - 11 Avenue Jean Capelle - 69621 Villeurbanne Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://carmen.univ-lyon1.fr/</ref>
</desc>
<listRelation><relation name="U1060" active="#struct-303623" type="direct"></relation>
<relation active="#struct-300074" type="direct"></relation>
<relation active="#struct-194495" type="direct"></relation>
<relation active="#struct-219748" type="direct"></relation>
<relation name="USC-1235" active="#struct-92114" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="U1060" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300074" type="direct"><org type="institution" xml:id="struct-300074" status="VALID"> <orgName>Hospices Civils de Lyon</orgName>
<desc> <address> <country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-194495" type="direct"><org type="institution" xml:id="struct-194495" status="VALID"><orgName>Université Claude Bernard Lyon 1</orgName>
<orgName type="acronym">UCBL</orgName>
<desc><address><addrLine>43, boulevard du 11 novembre 1918, 69622 Villeurbanne cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-lyon1.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-219748" type="direct"><org type="institution" xml:id="struct-219748" status="VALID"><orgName>Institut National des Sciences Appliquées Lyon</orgName>
<orgName type="acronym">INSA Lyon</orgName>
<desc><address><addrLine>20 Avenue Albert Einstein, 69621 Villeurbanne cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.insa-lyon.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="USC-1235" active="#struct-92114" type="direct"><org type="institution" xml:id="struct-92114" status="VALID"> <orgName>Institut National de la Recherche Agronomique</orgName>
<orgName type="acronym">INRA</orgName>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.inra.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<orgName type="university">Université Claude Bernard Lyon 1</orgName>
<orgName type="institution" wicri:auto="newGroup">Université de Lyon</orgName>
</affiliation>
</author>
</analytic>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="mix" xml:lang="en"><term>Biosciences</term>
<term>Blood-Brain barrier</term>
<term>Brain</term>
<term>Docosahexaenoic acid</term>
<term>Lysophosphatidylcholine</term>
<term>Molecular biology</term>
<term>Transport</term>
</keywords>
<keywords scheme="mix" xml:lang="fr"><term>Acide docosahéxaénoïque</term>
<term>Barrière hemato-Encéphalique</term>
<term>Biologie moléculaire</term>
<term>Cerveau</term>
<term>Lysophosphatidycholine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Docosahexaenoic acid (DHA, 22:6n-3) is the main essential omega-3 fatty acid in brain tissues required for normal brain development and function. A decrease in the cerebral concentration of DHA is observed in patients suffering from neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Targeted intake of DHA to the brain could compensate for these deficiencies. Blood DHA is transported across the blood-brain barrier (BBB) more efficiently when esterified at the sn-2 position of lysophosphatidylcholine (lysoPC). We produce in the laboratory a structured phosphatidylcholine to mimic 2-docosahexaenoyl-lysoPC (lysoPC-DHA), named AceDoPC (1-acetyl,2-docosahexaenoyl-glycerophosphocholine), that may be considered as a stabilized form of the physiological lysoPC-DHA and that is neuroprotective in experimental ischemic stroke. The first objective of this work was to compare the passage of either labeled unesterified DHA or DHA esterified in AceDoPC or in phosphatidylcholine (PC-DHA), bound to plasma, through an in vitro model of the BBB. This model is constituted of a co-culture of bovine brain capillary endothelial cells and glial cells from newborn rats. We show a preferential passage through the endothelial monolayer and a preferential uptake by glial cells of AceDoPC compared to unesterified DHA and PC-DHA. We also show that AceDoPC is hydrolyzed, partly, into lysoPC-DHA and that phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are the most labeled lipid classes in endothelial cells and glial cells. AceDoPC is found, partly, as a whole molecule in the cells. The second objective of this work was to confirm whether this preference for AceDoPC was also observed in vivo. We studied, in 20 days old rats, the brain uptake of different forms of DHA previously used (DHA, AceDoPC, PC-DHA). We demonstrate that AceDoPC provided the brain with DHA more efficiently than the other forms of DHA and that this preference for AceDoPC is specific for the brain because it is not observed for other studied organs. AceDoPC is found, partly, intact in the brain. Ex vivo autoradiography of rat brain reveals that DHA provided from AceDoPC is localized in specific brain regions playing key roles in memory and cognitive functions. Finally, by using molecular modelling approaches, we demonstrate that electrostatic and hydrophobic potentials are distributed very similarly at the surfaces of AceDoPC and lysoPC-DHA. In conclusion, our studies demonstrate that AceDoPC is a privileged and specific carrier of DHA to the brain. Considering the essential roles of DHA for the brain, this new approach to target the brain with DHA offers promising perspectives in the development of preventive and therapeutic strategies for neurological diseases.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Lyon</li>
</settlement>
<orgName><li>Université Claude Bernard Lyon 1</li>
<li>Université de Lyon</li>
</orgName>
</list>
<tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Hachem, Mayssa" sort="Hachem, Mayssa" uniqKey="Hachem M" first="Mayssa" last="Hachem">Mayssa Hachem</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000422 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000422 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= Hal:tel-01368259 |texte= Study of passage of a structured phospholipid "AceDoPC" through an in vitro reconstituted blood-brain barrier and its cerebral bioavailability in vivo in rats }}
This area was generated with Dilib version V0.6.29. |